CompoAtlas

SYNERPHYT N°4 CALME ET SOMMEIL

Food supplement declared in France, declaration No 2023-8-1286, decision dated 25 August 2023

SYNERPHYT N°4 CALME ET SOMMEIL (SYNPHONAT) is a food supplement declared in France. Status: declared in France, may be marketed. 1 rule of use applies to its ingredients (limits and warnings).

Brand
SYNPHONAT
Food business operator placing the product on the market
Prom'innov Synphonat
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Bottle
Daily dose
10 ml
Directions for use
Prendre 5 ml deux fois par jour dans une peu d'eau. En dehors de repas.
Not recommended (according to the manufacturer)
Breastfeeding women, Children (under 12), Young children (aged 1 to 3), Infants (under 1 year), Liver problems, Taking blood pressure medication, Children (under 6), Children (under 10)
Objectives stated by the manufacturer (these are not authorised claims)
Sleep, Nervous system

Declaration 134198, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Crataegus laevigata (Poir.) DC.Sommités fleuriesExtrait fluide aqueux291 mg
Citrus aurantium L.FeuilleExtrait fluide aqueux243 mg
Tilia × europaea L.FeuilleExtrait fluide aqueux243 mg
Papaver rhoeas L.PétalesExtrait fluide aqueux194 mg

Other active ingredients

NamePer day
miel d’acacianot declared
Glycinenot declared

Additives

E422, E330, E202, E211

Other ingredients

eau

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

Regulatory points

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Crataegus laevigata (Poir.) DC.
    Read the warning, when it applies and the studies cited

    Hawthorn

    Route of administration: Oral (ESCOP 2009; Bradley 2006; Mills and Bone 2000)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking cardiac glycosides (e.g., digoxin) or blood pressure or heart medications (Brinker 2010; Bradley 2006).

    Sources cited by Health Canada (2)
    • Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (GB): British Herbal Medicine Association; 2006.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have chest pain, irregular heartbeat, or shortness of breath.

    Health Canada monograph dated 31 July 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : SYNPHONAT

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

List recorded in 2023. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line